The Schild regression in the process of receptor classification

Canadian Journal of Physiology and Pharmacology
Terry Kenakin


The history and derivation of the Schild equation is reviewed as well as the conditions under which the intercept of a Schild regression (the pA2, an empirical quantity) can be considered to be an estimate of the equilibrium dissociation constant of the antagonist for the receptor (KB). This parameter is of value in the classification of receptors. To be considered competitive (and, therefore, to be described in molecular terms by a KB), an antagonist must produce parallel displacement of agonist concentration-response curves with no alteration in the maximal response and thereby yield unambiguous dose ratios of agonist which are independent of agonist concentration. These dose ratios (dr) then can be utilized in the Schild equation (log (dr = 1) = n . log [B] - log KB, where [B] is the molar concentration of antagonist) in the form of a regression of log (dr - 1) on log [B]. If the regression is linear and has a slope of unity, the blockade is consistent with simple competitive antagonism and the intercept can be considered an estimate of the KB. Experimentally, the slope is a parameter critical to the assessment of competitivity. While a slope significantly different from unity may indicate that an antagonist is not competiti...Continue Reading


Dec 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·T ShojiT Shigei
Sep 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·E N JubergP W Abel
Mar 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·C J WhelanG P Wren
Jan 27, 1984·European Journal of Pharmacology·D RegoliJ Mizrahi
Oct 1, 1984·European Journal of Pharmacology·J C Hunter, J E Maggio
Oct 14, 1986·European Journal of Pharmacology·L Churchill, P E Ward
Nov 19, 1986·European Journal of Pharmacology·B Fallgren, L Edvinsson
Oct 11, 1988·European Journal of Pharmacology·I Ahnfelt-RønneC Kaergaard-Nielsen
Sep 4, 1991·European Journal of Pharmacology·M J PostA J Porsius
May 2, 1991·European Journal of Pharmacology·T A Bökesoy, H O Onaran
Oct 31, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·F R SchulzeW Schunack
Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R J GouldS H Snyder
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·D G SawutzM M Awad
Dec 23, 2008·The Journal of Pharmacology and Experimental Therapeutics·Jun-Xu LiCharles P France
Jul 7, 2011·The Journal of Pharmacology and Experimental Therapeutics·Emily M JutkiewiczJames H Woods
Aug 21, 2013·Biochemical Pharmacology·Terry Kenakin, Michael Williams
Dec 1, 1983·Journal of Pharmacological Methods·S A Doggrell
Dec 20, 2015·Journal of Neurochemistry·Nathalie SchmiegClotilde Mannoury la Cour
Nov 2, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gianluigi D'AgostinoAnnalisa Barbieri
Jan 1, 1991·General Pharmacology·R C Spadari, S de Moraes
Mar 27, 1990·European Journal of Pharmacology·M Isla, D C Dyer
Mar 21, 2016·The International Journal of Biochemistry & Cell Biology·Appalaraju JaggupilliPrashen Chelikani
May 1, 1987·British Journal of Pharmacology·J B CalixtoR A Yunes
Apr 1, 1984·British Journal of Pharmacology·R D Pinnock
Oct 1, 1982·British Journal of Pharmacology·J A Leedham, J N Pennefather
Nov 25, 2003·American Journal of Obstetrics and Gynecology·Andrea E ErrastiRodolfo P Rothlin
Dec 3, 2014·Insect Biochemistry and Molecular Biology·Heleen VerlindenAlison Mercer
Sep 15, 2004·European Journal of Pharmacology·Federico M DarayRodolfo P Rothlin
Sep 1, 2008·Current Protocols in Pharmacology·Terry Kenakin
Apr 1, 1988·Medicinal Research Reviews·P Leff, G R Martin
Dec 1, 1984·Journal of Autonomic Pharmacology·T Skärby, K E Andersson
Sep 1, 1984·Journal of Autonomic Pharmacology·E D Högestätt, K E Andersson
May 30, 1997·Annals of the New York Academy of Sciences·L C MartiniA Jurkiewicz
Jun 28, 2011·American Journal of Respiratory Cell and Molecular Biology·Luigino CalzettaMaria Gabriella Matera
Jul 28, 2013·The Journal of Pharmacology and Experimental Therapeutics·Magdolna LevayThomas Wieland
May 7, 2002·Canadian Journal of Physiology and Pharmacology·Bachtiar IndraYasushi Ohizumi
Jun 25, 2016·The Journal of Biological Chemistry·Maria Risager JensenThomas Vorup-Jensen
Feb 1, 2011·American Journal of Respiratory Cell and Molecular Biology·Mario CazzolaMaria Gabriella Matera
May 1, 1985·The Journal of Pharmacy and Pharmacology·L BradleyS C Edmonds
Dec 1, 1982·Journal of Autonomic Pharmacology·R R Ruffolo
Nov 1, 1984·Acta Pharmacologica Et Toxicologica·S SteenK E Andersson
Mar 1, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Az Alddien NatfjiFrancesca Greco
Oct 1, 1993·The American Journal of Physiology·B Kanyicska, M E Freeman

Related Concepts

Dose-Response Relationship, Drug
Receptors, Drug

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.